Global Rat Model Market Reaches $1.5 Billion in 2025, Driven by Steady 7.6% Growth

Global rat model market was valued at $1.5 billion in 2025 and is growing at a CAGR of 7.6% during the forecast period (2026-2035). The market growth is driven by rising R&D in pharma/biotech, advancements in genetic engineering (like CRISPR) for creating precise models, increased focus on personalized medicine, and demand for models in drug discovery, disease modeling (oncology, neurology), and toxicology studies, with key segments including genetically engineered/knockout and humanized rats, serving academia and industry globally, particularly in North America. Key factors boosting this are increased outsourcing, government support, and the need for reliable models for complex human diseases.

Browse the full report description of “Rat Model Market Size, Share & Trends Analysis by Technology (Micro Injection, Embryonic Stem Cell Injection, Nuclear Transferase Technology, and CRISPR), By Type (Inbred Rats, Knockout Rats, Outbred Rats, and Others), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/rat-model-market

As per the National Center for Chronic Disease Prevention and Health Promotion Org., in October 2024, Market growth is driven by the rising global prevalence of chronic diseases, including cardiovascular disorders, diabetes, cancer, and neurological conditions, which increases the demand for validated preclinical disease models. Chronic diseases like heart disease, cancer, and diabetes are the top causes of death and disability in the US and significantly contribute to the nation's annual health care costs, totaling $4.9 trillion.

Three in four American adults have at least one chronic condition, and over half have two or more chronic conditions, such as

• Among adults ages 65 and older, more than 90% have at least one chronic condition.
• Among midlife adults ages 35–64, more than 75% have at least one condition.
• Among younger adults ages 18–34, 60% have at least one condition.

Many preventable chronic diseases are caused by a short list of risk behaviors: smoking, poor nutrition, physical inactivity, and excessive alcohol use.

Key Innovators Driving Rat Model Transformation

The key players in the Rat Model market include Charles River Laboratories International, Inc., Envigo (Inotiv, Inc.), genOway, Janvier Labs, Taconic Biosciences, Inc., among others. These companies are driving innovation in digital health solutions such as telemedicine, electronic health records, remote patient monitoring, and AI-powered clinical tools, shaping the future of healthcare delivery globally.

• In October 2024, Physiogenex introduced a new rat model for IgA nephropathy (IgAN), designed to facilitate quick evaluation of drug efficacy within 8 days. Key assessments include Glomerular Filtration Rate (GFR), urine parameters, and kidney histology. Additionally, collaboration with Nipoka and Aiosyn enables histology image analysis to measure podocyte effacement and mesangial expansion.
• In December 2024, Researchers have created a double-hit rat model of Parkinson's disease, combining genetic susceptibility and toxin-induced inflammation to drive neurodegeneration. This model mirrors the neurodegeneration observed in Parkinson's patients more closely than traditional models, which only exhibit genetic risk. The study reveals that the progressive loss of dopaminergic neurons in Parkinson's disease may be influenced by a combination of genetic and environmental factors, in addition to neuroinflammation. The model aims to deepen the understanding of how these factors interact in the context of Parkinson's disease.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Technology
  • By Type
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - Charles River Laboratories International, Inc., Envigo (Inotiv, Inc.), genOway, Janvier Labs, Taconic Biosciences, Inc., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Rat Model Market Report Segment

By Technology

• Micro Injection
• Embryonic Stem Cell Injection
• Nuclear Transferase Technology
• CRISPR

By Type

• Inbred Rats
• Knockout/Genetically Engineered Rats
• Outbred Rats
• Others

Global Rat Model Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/rat-model-market